Al White

Al White leads Cooper Companies, a diversified medical device company with two operating segments that share the common thread of improving quality of life. CooperVision is the world's third-largest contact lens manufacturer, competing with Johnson & Johnson Vision (Acuvue) and Alcon (the market leaders). CooperSurgical provides medical devices, fertility solutions, and genomics services for women's healthcare. CooperVision has been one of the fastest-growing contact lens companies, gaining market share through innovation in specialty lenses — particularly myopia management (MiSight, the first FDA-approved contact lens for slowing myopia progression in children), toric lenses (for astigmatism), and multifocal lenses (for presbyopia). The global contact lens market benefits from structural growth: increasing myopia prevalence worldwide (particularly in Asia), the shift from glasses to contacts, and daily disposable lens adoption. CooperSurgical's fertility business has become increasingly valuable as fertility treatment demand grows globally — driven by delayed parenthood, increased awareness, and insurance coverage expansion. The company provides IVF laboratory products, genetic testing, and donor services. Key stock drivers include contact lens market growth, CooperVision market share gains, myopia management lens adoption, fertility treatment volumes, pricing and ASP trends, and competitive dynamics with J&J Vision and Alcon.